UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 151

Sortiert nach

Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report

BMC infectious diseases, 2019-01, Vol.19 (1), p.66-66, Article 66

2019

Volltextzugriff (PDF)

Liver transplantation for severe alcoholic hepatitis–The CON view

Liver international, 2017-03, Vol.37 (3), p.340-342

Fung, James Y. Y.

2017

Volltextzugriff (PDF)

Recurrent pyogenic cholangitis: An indication for liver transplantation

Hepatobiliary & pancreatic diseases international, 2022-08, Vol.21 (4), p.396-398

2022

Volltextzugriff (PDF)

Prevention of recurrent hepatitis B infection after liver transplantation

Hepatobiliary & pancreatic diseases international, 2013-10, Vol.12 (5), p.465-472

2013

Volltextzugriff (PDF)

Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses

Annals of surgical oncology, 2019-05, Vol.26 (5), p.1454-1462

2019

Volltextzugriff (PDF)

Commentary: Direct-acting antiviral regimens usher in the era of hepatitis C virus–positive donors in lung transplant

The Journal of thoracic and cardiovascular surgery, 2019-10, Vol.158 (4), p.e159-e160

2019

Volltextzugriff (PDF)

Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion

Hepatology international, 2012-06, Vol.6 (3), p.646-656

2012

Volltextzugriff (PDF)

Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area

Annals of surgery, 2017-01, Vol.265 (1), p.173-177

2017

Volltextzugriff (PDF)

Emergency ABO-incompatible living donor liver transplant for patients with ultrahigh MELD scores

Hepatobiliary & pancreatic diseases international, 2019-02, Vol.18 (1), p.87-89

2019

Volltextzugriff (PDF)

Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia

Journal of hepatology, 2013-11, Vol.59 (5), p.1073-1080

2013

Volltextzugriff (PDF)

Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation

Expert opinion on emerging drugs, 2017-04, Vol.22 (2), p.123-136

2017

Volltextzugriff (PDF)

Liver transplantation and hepatitis B virus infection: towards an immunoglobulin-free antiviral treatment after transplantation

Current opinion in organ transplantation, 2016-04, Vol.21 (2), p.219-223

2016

Volltextzugriff (PDF)

Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation

Hepatology international, 2017-11, Vol.11 (6), p.517-522

2017

Volltextzugriff (PDF)

New insights after the first 1000 liver transplantations at The University of Hong Kong

Asian journal of surgery, 2016-10, Vol.39 (4), p.202-210

2016

Volltextzugriff (PDF)

868: PREVENTING HEPATCELLULAR CARCINOMA WITH TENOFOVIR VS ENTECAVIR: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF PROPENSITY SCORE MATCHED STUDIES

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1138-S-1139

2022

Volltextzugriff (PDF)

REPLY

Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2620-2620

2021

Volltextzugriff (PDF)

REPLY

Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2620

2021

Volltextzugriff (PDF)

REPLY

Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2620-2620

2021

Volltextzugriff (PDF)

Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation: Pilot Study on Hifu Ablation as Bridging Therapy

Liver transplantation, 2014-08, Vol.20 (8), p.912-921

2014

Volltextzugriff (PDF)

11 C-Acetate and 18 F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon’s Perspective

Journal of Nuclear Medicine, 2013-02, Vol.54 (2), p.192-200

2013

Volltextzugriff (PDF)

sup 11^C-Acetate and ^sup 18^F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon's Perspective

The Journal of nuclear medicine (1978), 2013-02, Vol.54 (2), p.192

2013

Volltextzugriff (PDF)

Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8cm in diameter

HPB (Oxford, England), 2014-08, Vol.16 (8), p.749-757

2014

Volltextzugriff (PDF)

Increasing the recipient benefit/donor risk ratio by lowering the graft size requirement for living donor liver transplantation: Lowering Graft Size Requirement Lowers Donor Risk

Liver transplantation, 2012-09, Vol.18 (9), p.1078-1082

2012

Volltextzugriff (PDF)

CD8 + T-cell plasticity regulates vascular regeneration in type-2 diabetes

Theranostics, 2020-01, Vol.10 (9), p.4217-4232

2020

Volltextzugriff (PDF)

Decreased diastolic hydraulic forces incrementally associate with survival beyond conventional measures of diastolic dysfunction

Scientific reports, 2023-09, Vol.13 (1), p.16396-16396, Article 16396

2023

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(144)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report

Liver transplantation for severe alcoholic hepatitis–The CON view

Recurrent pyogenic cholangitis: An indication for liver transplantation

Prevention of recurrent hepatitis B infection after liver transplantation

Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses

Commentary: Direct-acting antiviral regimens usher in the era of hepatitis C virus–positive donors in lung transplant

Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion

Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area

Emergency ABO-incompatible living donor liver transplant for patients with ultrahigh MELD scores

Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia

Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation

Liver transplantation and hepatitis B virus infection: towards an immunoglobulin-free antiviral treatment after transplantation

Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation

New insights after the first 1000 liver transplantations at The University of Hong Kong

868: PREVENTING HEPATCELLULAR CARCINOMA WITH TENOFOVIR VS ENTECAVIR: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF PROPENSITY SCORE MATCHED STUDIES

REPLY

REPLY

REPLY

Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation: Pilot Study on Hifu Ablation as Bridging Therapy

11 C-Acetate and 18 F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon’s Perspective

sup 11^C-Acetate and ^sup 18^F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon's Perspective

Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8cm in diameter

Increasing the recipient benefit/donor risk ratio by lowering the graft size requirement for living donor liver transplantation: Lowering Graft Size Requirement Lowers Donor Risk

CD8 + T-cell plasticity regulates vascular regeneration in type-2 diabetes

Decreased diastolic hydraulic forces incrementally associate with survival beyond conventional measures of diastolic dysfunction

Aktive Filter

Suchergebnisse filtern